ABC-DLBCL is a molecular subtype characterized by poor outcomes, and it is associated with the constitutive activation of NF-κB, controlling and promoting the cell proliferation, survival and gene expression (90). The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.